← FDA Drug Approvals (Drugs@FDA)
CIPROFLOXACIN AND DEXAMETHASONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SENTISS · Approved 2023-06-09
Drug application
- FDA Application #
ANDA215768- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CIPROFLOXACIN AND DEXAMETHASONE
- Generic name
- CIPROFLOXACIN AND DEXAMETHASONE
- Active ingredients
- CIPROFLOXACIN; DEXAMETHASONE
- Dosage form
- SUSPENSION/DROPS
- Route
- OTIC
- Marketing status
- Prescription
- Sponsor
- SENTISS
- Manufacturer
- ARMAS PHARMACEUTICALS INC.
- First approval
- 2023-06-09
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown